Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I Study of Continuous Infusion Gemcitabine

NCT00020644 is registered in ClinicalTrials.gov with Advocate Lutheran General Hospital as lead sponsor.

NCT NCT00020644
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00020644 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I Study of Continuous Infusion Gemcitabine
Lead sponsor
Advocate Lutheran General Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
March 31, 2000
Completion date
Not reported
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

unspecified adult solid tumor, protocol specific